Insider Shareholders with Direct Ownership of Biocryst Pharmaceuticals Inc (BCRX)
This section provides a comprehensive overview of the insiders with direct ownership of Biocryst Pharmaceuticals Inc (BCRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
BIOCRYST PHARMACEUTICALS INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Jon P Stonehouse
President & CEO |
1,517,006 | 884,167 | 1,101,019 $11.1 Million | 26 |
Dec 14, 2024
Reduced 2.44%
|
|
Charles K Gayer
Chief Commercial Officer |
348,950 | 25,134 | 423,546 $4.28 Million | 10 |
Dec 19, 2024
Reduced 0.58%
|
|
Alane P Barnes
Chief Legal Officer |
464,814 | 152,008 | 412,729 $4.17 Million | 17 |
Dec 19, 2024
Reduced 0.59%
|
|
Anthony Doyle
Chief Financial Officer |
375,258 | 24,008 | 377,867 $3.82 Million | 11 |
Dec 19, 2024
Reduced 0.65%
|
|
Helen M. Thackray
Chief R&D Officer |
431,950 | 54,632 | 377,318 $3.81 Million | 15 |
Mar 31, 2025
Reduced 1.96%
|
|
Yarlagadda S Babu
Chief Discovery Officer |
247,000 | 104,046 | 298,541 $3.02 Million | 8 |
Nov 14, 2022
Reduced 9.55%
|
|
Robert Alexander Ingram
Director |
30,593 | 0 | 100,198 $1.01 Million | 11 |
Feb 28, 2023
Added 2.2%
|
|
Nancy J Hutson
Director |
184,022 | 148,199 | 99,138 $1 Million | 14 |
Jun 12, 2025
Added 11.2%
|
|
Vincent Milano
Director |
79,760 | 0 | 89,760 $906,576 | 18 |
Jun 12, 2025
Added 12.22%
|
|
Steve Aselage
Director |
41,546 | 0 | 70,159 $708,605 | 10 |
Jun 12, 2024
Added 8.86%
|
|
Kenneth B Lee Jr
Director |
59,611 | 6,000 | 68,863 $695,516 | 5 |
Jun 13, 2023
Added 19.56%
|
|
Theresa Heggie
Director |
59,642 | 6,698 | 65,352 $660,055 | 20 |
Jun 12, 2025
Added 16.06%
|
|
Alan G Levin
Director |
64,271 | 0 | 64,271 $649,137 | 13 |
Jun 12, 2025
Added 16.28%
|
|
Amy E Mc Kee
Director |
48,931 | 8,600 | 40,331 $407,343 | 5 |
Jun 12, 2025
Added 23.66%
|
|
Machelle Sanders
Director |
48,931 | 8,689 | 40,242 $406,444 | 6 |
Jun 12, 2025
Added 23.7%
|
|
William P Sheridan
Chief Medical Officer |
388,125 | 365,962 | 37,954 $383,335 | 9 |
Mar 10, 2022
Reduced 3.56%
|
|
George B Abercrombie
Director |
139,098 | 112,667 | 36,431 $367,953 | 18 |
Jun 12, 2024
Added 15.77%
|
|
Steven K Galson
Director |
70,871 | 0 | 24,991 $252,409 | 5 |
Jun 12, 2025
Added 33.34%
|
|
Michael L Jones
Exec. Director, Finance - PAO |
27,150 | 11,345 | 16,653 $168,195 | 8 |
Dec 19, 2022
Added 26.16%
|
|
Steven Frank
Director |
14,699 | 0 | 14,699 $148,459 | 3 |
Jun 12, 2025
Added 45.96%
|